BioAge Labs (BIOA) Gains from Investment Securities (2024 - 2026)
BioAge Labs (BIOA) posted Gains from Investment Securities of $107000.0 for Q1 2026, down 51.36% sequentially from $220000.0 in Q4 2025, and up 281.36% YoY from $28057.8 in Q1 2025.
BioAge Labs (BIOA) Gains from Investment Securities (2024 - 2026) Analysis & Trends
BioAge Labs has reported Gains from Investment Securities for 3 years, with the latest figure at $107000.0 in Q1 2026.
- Quarterly Gains from Investment Securities rose 281.36% year-over-year to $107000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $380000.0 (up 371.43% YoY) and the FY2025 annual result came in at $214000.0, up 393.15% from the prior year.
- Gains from Investment Securities eased to $107000.0 in Q1 2026 per BIOA's latest filing, from $220000.0 in the prior quarter.
- Over five years, Gains from Investment Securities peaked at $306000.0 in Q3 2024 and troughed at -$457000.0 in Q4 2024.
- A 3-year average of $27555.6 and a median of $42000.0 in 2025 frame the typical range for Gains from Investment Securities.
- The sharpest annual moves came in 2025 and 2026: Gains from Investment Securities slumped 837.5% in 2025, then soared 281.36% in 2026.
- Over 3 years, Gains from Investment Securities stood at -$457000.0 in 2024, then jumped by 148.14% to $220000.0 in 2025, then tumbled by 51.36% to $107000.0 in 2026.
- According to Business Quant data, Gains from Investment Securities over the past three periods registered $107000.0, $220000.0, and $42000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - |
| 10 | BioAge Labs | 434.04 Mn | 434.04 Mn | -14.23 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 201,000.00 |
| Jun 30, 2026 | 201,000.00 |
| Mar 31, 2026 | 107,000.00 |
| Mar 31, 2026 | 107,000.00 |
| Dec 31, 2025 | 220,000.00 |
| Dec 31, 2025 | 220,000.00 |
| Sep 30, 2025 | 42,000.00 |
| Sep 30, 2025 | 42,000.00 |
| Jun 30, 2025 | 11,000.00 |
| Jun 30, 2025 | 11,000.00 |
| Mar 31, 2025 | -59,000.00 |
| Mar 31, 2025 | -59,000.00 |
| Dec 31, 2024 | -457,000.00 |
| Dec 31, 2024 | -457,000.00 |
| Sep 30, 2024 | 306,000.00 |
| Sep 30, 2024 | 306,000.00 |
| Jun 30, 2024 | 70,000.00 |
| Jun 30, 2024 | 70,000.00 |
| Mar 31, 2024 | 8,000.00 |
| Mar 31, 2024 | 8,000.00 |